Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Keyt Bruce, Chief Scientific Officer. Director active across 1 company, notably IGM Biosciences, Inc.. In total, 36 reports have been published. Split: 0 buy · 8 sells. Total volume traded: €190k. Activity tracked since 3 May 2021. The latest transaction was disclosed on 13 September 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Keyt Bruce
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Keyt Bruce is Chief Scientific Officer at IGM Biosciences, Inc. This insider has filed 36 filings in total, and across the sampled recent filings from 2021-05-05 to 2024-09-17, sales total EUR 190239 and the most frequent transaction nature is option exercise.